Advances in Therapies and Imaging for Systemic Vasculitis

Area of Science:

• Immunology
• Radiology
• Rheumatology

Background:

• Vasculitis involves immune-mediated blood vessel injury, posing treatment challenges due to side effects of current therapies like glucocorticoids.
• Lack of robust disease activity markers complicates management for both small and large vessel vasculitis.
• Understanding vasculitis pathogenesis has spurred development of novel biologic therapies targeting inflammatory pathways.

Purpose of the Study:

• To review recent advances in understanding vasculitis pathogenesis.
• To explore emerging biologic therapies for vasculitis.
• To discuss novel imaging modalities for monitoring vascular inflammation.

Main Methods:

• Review of current literature on vasculitis pathogenesis and treatment.
• Analysis of novel biologic therapies targeting inflammatory cascades.
• Evaluation of advanced imaging techniques including PET-CT and MRI for vascular inflammation.

Main Results:

• Novel biologic therapies show promise in targeting key inflammatory effectors in vasculitis.
• Emerging imaging modalities, including PET-CT and MRI, offer potential for longitudinal tracking of vascular inflammation.
• New radiotracers for macrophage activation and immune checkpoint activity represent a frontier in imaging vasculitis.

Conclusions:

• Advances in understanding vasculitis pathogenesis are leading to targeted biologic therapies.
• Combined structural and molecular imaging techniques are expected to provide reliable monitoring of vascular inflammation.
• Future imaging advancements will enable more precise disease assessment for individualized patient management in vasculitis.